Blood pressure from mid- to late life and risk of incident dementia

被引:180
作者
McGrath, Emer R. [1 ,2 ,3 ]
Beiser, Alexa S. [4 ,5 ,6 ]
DeCarli, Charles [7 ]
Plourde, Kendra L. [5 ]
Vasan, Ramachandran S. [4 ,5 ,6 ]
Greenberg, Steven M. [2 ,3 ]
Seshadri, Sudha [4 ,6 ]
机构
[1] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Boston Univ, Sch Med, Boston, MA 02215 USA
[5] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA
[6] Framingham Heart Dis Epidemiol Study, Framingham, MA USA
[7] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA
关键词
ALZHEIMERS-DISEASE; SYSTOLIC HYPERTENSION; COGNITIVE FUNCTION; DOUBLE-BLIND; BRAIN; ASSOCIATION; PREVENTION; DIAGNOSIS; STROKE; IMPACT;
D O I
10.1212/WNL.0000000000004741
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To determine the association between blood pressure during midlife (40-64 years) to late life (>= 65 years) and risk of incident dementia. Methods: This study included 1,440 (758 women, mean age 69 66 years) Framingham Offspring participants who were free of dementia and attended 5 consecutive examinations at 4-year intervals starting at midlife (1983-1987, mean age 55 years) until late life (1998-2001, mean 69 years) and subsequently were followed up for incident dementia (mean 8 years). We determined the effect of midlife hypertension (>= 140/90 mm Hg), late life hypertension, lower late life blood pressure (<100/70 mm Hg), persistence of hypertension during mid-to late life, and steep decline in blood pressure from mid-to late life over an 18-year exposure period. Results: During the follow-up period, 107 participants (71 women) developed dementia. Using multivariable Cox proportional hazards models, we found that midlife systolic hypertension (hazard ratio [HR] 1.57, 95% confidence interval [CI] 1.05-2.35) and persistence of systolic hypertension into late life (HR 1.96, 95% CI 1.25-3.09) were associated with an elevated risk of incident dementia. However, in individuals with low to normal blood pressure (<= 140/90 mm Hg) at midlife, a steep decline in systolic blood pressure during mid-to late life was also associated with a chi(2)-fold increase in dementia risk (HR 2.40, 95% CI 1.39-4.15). Conclusions: Elevated blood pressure during midlife, persistence of elevated blood pressure into late life, and, among nonhypertensives, a steep decline in blood pressure during mid-to late life were associated with an increased dementia risk in a community-based cohort. Our data highlight the potential sustained cognitive benefits of lower blood pressures in midlife but also suggest that declining blood pressure in older adults with prehypertension or normotension, but not in those with hypertension, may be a risk marker for dementia.
引用
收藏
页码:2447 / 2454
页数:8
相关论文
共 36 条
  • [1] Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies
    Anderson, Craig
    Teo, Koon
    Gao, Peggy
    Arima, Hisatomi
    Dans, Antonio
    Unger, Thomas
    Commerford, Patrick
    Dyal, Leanne
    Schumacher, Helmut
    Pogue, Janice
    Paolasso, Ernesto
    Holwerda, Nicolaas
    Chazova, Irina
    Binbrek, Azan
    Young, James
    Yusuf, Salim
    [J]. LANCET NEUROLOGY, 2011, 10 (01) : 43 - 53
  • [2] IMPACT OF THE TREATMENT OF ISOLATED SYSTOLIC HYPERTENSION ON BEHAVIORAL VARIABLES - RESULTS FROM THE SYSTOLIC HYPERTENSION IN THE ELDERLY PROGRAM
    APPLEGATE, WB
    PRESSEL, S
    WITTES, J
    LUHR, J
    SHEKELLE, RB
    CAMEL, GH
    GREENLICK, MR
    HADLEY, E
    MOYE, L
    PERRY, HM
    SCHRON, E
    WEGENER, V
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (19) : 2154 - 2160
  • [3] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [4] Alzheimer disease as a vascular disorder - Nosological evidence
    de la Torre, JC
    [J]. STROKE, 2002, 33 (04) : 1152 - 1162
  • [5] Association between blood pressure levels over time and brain atrophy in the elderly
    den Heijer, T
    Skoog, I
    Oudkerk, M
    de Leeuw, FE
    de Groot, JC
    Hofman, A
    Breteler, MMB
    [J]. NEUROBIOLOGY OF AGING, 2003, 24 (02) : 307 - 313
  • [6] Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial:: a double-blind, active and placebo-controlled study
    Dienert, Hans-Christoph
    Saccot, Ralph L.
    Yusuft, Salim
    Cotton, Daniel
    Ounpuu, Stephanie
    Lawton, William A.
    Palesch, Yuko
    Martin, Renee H.
    Albers, Gregory W.
    Bath, Philip
    Bornstein, Natan
    Chan, Bernard P. L.
    Chen, Sien-Tsong
    Cunha, Luis
    Dahlof, Bjorn
    De Keyser, Jacques
    Donnan, Geoffrey A.
    Estol, Conrado
    Gorelick, Philip
    Gu, Vivian
    Hermansson, Karin
    Hilbrich, Lutz
    Kaste, Markku
    Lu, Chuanzhen
    Machnig, Thomas
    Pais, Prem
    Roberts, Robin
    Skvortsova, Veronika
    Teal, Philip
    Toni, Danilo
    VanderMaelen, Cam
    Voigt, Thor
    Weber, Michael
    Yoon, Byung-Woo
    [J]. LANCET NEUROLOGY, 2008, 7 (10) : 875 - 884
  • [7] FRAMINGHAM OFFSPRING STUDY - DESIGN AND PRELIMINARY DATA
    FEINLEIB, M
    KANNEL, WB
    GARRISON, RJ
    MCNAMARA, PM
    CASTELLI, WP
    [J]. PREVENTIVE MEDICINE, 1975, 4 (04) : 518 - 525
  • [8] Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
    Forette, F
    Seux, ML
    Staessen, JA
    Thijs, L
    Birkenhäger, WH
    Babarskiene, MR
    Babeanu, S
    Bossini, A
    Gil-Extremera, B
    Girerd, X
    Laks, T
    Lilov, E
    Moisseyev, V
    Tuomilehto, J
    Vanhanen, H
    Webster, J
    Yodfat, Y
    Fagard, R
    [J]. LANCET, 1998, 352 (9137) : 1347 - 1351
  • [9] Vascular Contributions to Cognitive Impairment and Dementia A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
    Gorelick, Philip B.
    Scuteri, Angelo
    Black, Sandra E.
    DeCarli, Charles
    Greenberg, Steven M.
    Iadecola, Costantino
    Launer, Lenore J.
    Laurent, Stephane
    Lopez, Oscar L.
    Nyenhuis, David
    Petersen, Ronald C.
    Schneider, Julie A.
    Tzourio, Christophe
    Arnett, Donna K.
    Bennett, David A.
    Chui, Helena C.
    Higashida, Randall T.
    Lindquist, Ruth
    Nilsson, Peter M.
    Roman, Gustavo C.
    Sellke, Frank W.
    Seshadri, Sudha
    [J]. STROKE, 2011, 42 (09) : 2672 - 2713
  • [10] Effects of Candesartan in Acute Stroke on Cognitive Function and Quality of Life Results From the Scandinavian Candesartan Acute Stroke Trial
    Hornslien, Astrid G.
    Sandset, Else C.
    Bath, Philip M.
    Wyller, Torgeir B.
    Berge, Eivind
    [J]. STROKE, 2013, 44 (07) : 2022 - 2024